Coronavirus channel feed

Ven­rock sur­vey shows grow­ing recog­ni­tion of coro­n­avirus toll, wan­ing con­fi­dence in ar­rival of vac­cines and treat­ments

5 years ago
R&D

Covid-19 roundup: Buoyed by soar­ing shares, No­vavax inks a $167M deal to buy Covid-19 vac­cine-mak­ing fa­cil­i­ty; France cools on hy­drox­y­chloro­quine

5 years ago

Biotech Voic­es: Coro­n­avirus will change biotech re­search with re­mote col­lab­o­ra­tions

5 years ago
Biotech Voices

Backed by BAR­DA, Mer­ck jumps in­to Covid-19: buy­ing out a vac­cine, part­ner­ing on an­oth­er and adding an­tivi­ral to the mix

5 years ago
R&D

Covid-19 roundup: Jun­shi, Eli Lil­ly ready to launch Covid-19 an­ti­body tri­al; Janet Wood­cock steps aside — for now — as FDA drug czar

5 years ago

Re­searchers de­fine ex­act­ly what they saw in the first pos­i­tive remde­sivir study for Covid-19. But what's that worth to Gilead?

5 years ago
Bioregnum
Opinion

Covid-19 roundup: CanSi­no beats Mod­er­na to pub­li­ca­tion of first-in-hu­man da­ta for a coro­n­avirus vac­cine

5 years ago

EMA ex­tends vir­tu­al-on­ly meet­ing pol­i­cy through Au­gust

5 years ago
FDA+

Covid-19 roundup: BAR­DA hands As­traZeneca $1B-plus to race through PhI­II and ramp up fall de­liv­er­ies of Ox­ford’s pan­dem­ic vac­cine

5 years ago

Mam­moth Bio­sciences teams with GSK to put Covid-19 CRISPR tests at home, air­ports, bor­ders

5 years ago

Covid-19 roundup: Hit with new con­flict ac­cu­sa­tions, Janet Wood­cock steps out of the agen­cy's Covid-19 chain of com­mand

5 years ago
R&D

Phar­mas­set co-founder jumps in­to Covid-19 fight, with a new com­pa­ny and $215 mil­lion to get there

5 years ago
Financing

FDA, Ae­tion part­ner on re­al-world da­ta an­a­lyt­ics for Covid-19

5 years ago
FDA+

How a Cal­i­for­nia biotech briefly tripled its val­ue by hyp­ing a Covid-19 ‘cure’

5 years ago
R&D

Covid-19 roundup: Trump says he's been tak­ing hy­drox­y­chloro­quine for days; Mod­er­na rais­es $1.3B on the heels of ground­break­ing da­ta

5 years ago

FDA up­dates Covid-19 clin­i­cal tri­als guid­ance to ad­dress se­ri­ous ad­verse events

5 years ago
FDA+

Mod­er­na posts a promis­ing snap­shot of hu­man da­ta for a lead­ing Covid-19 vac­cine — and ral­ly makes Bob Langer a bil­lion­aire

5 years ago
R&D

Covid-19 roundup: Kate Bing­ham to lead UK task­force; Fed­er­al judge to Shkre­li: You’re not go­ing to save the world, stay in prison

5 years ago

Serge Wein­berg is­sues sharp re­ver­sal as board, French gov­ern­ment re­act to CEO Paul Hud­son’s vac­cine re­marks

5 years ago
R&D

Covid-19 roundup: Trump ad­min­is­tra­tion prep­ping ex­ec or­der to re­duce re­liance on for­eign man­u­fac­tur­ing of 'essen­tial med­i­ci­nes'

5 years ago

Rick Bright de­tails mis­man­aged pan­dem­ic re­sponse, warns of drugs, vac­cine sup­ply prob­lems down the road; HHS push­es back

5 years ago
People

Covid-19 roundup: Count­ing 1,087 tri­als for coro­n­avirus, R&D ex­perts say much of it is a com­plete waste; WHO sci­en­tist por­tends it will be 'years' be­fore Covid-19 threat will be con­tained

5 years ago

It's Mon­cef Slaoui. Trump ad­min­is­tra­tion set­tles on ex-GSK vac­cines chief as Covid-19 R&D czar — re­ports

5 years ago
People

Sanofi walks back Paul Hud­son’s promise of ear­ly vac­cine ac­cess for the US, French min­is­ters call it 'u­nac­cept­able'

5 years ago
R&D
First page Previous page 50515253545556 Next page Last page
A service from the Financial Times